Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC

Name: Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC
License: Public Domain

Dr Joanne CHIU

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

nsclc, egfr activating mutation, egf-r positive non-small cell lung cancer, alk gene rearrangement positive, ros1 gene rearrangement, ros1 positive nsclc - reactive oxygen species 1 positive non-small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 332765
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.